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Although L-serine proceeds in just three steps from the glycolytic intermediate 3-phosphoglycerate, and as
much as 8% of the carbon assimilated from glucose is directed via L-serine formation, previous attempts to
obtain a strain producing L-serine from glucose have not been successful. We functionally identified the genes
serC and serB from Corynebacterium glutamicum, coding for phosphoserine aminotransferase and phospho-
serine phosphatase, respectively. The overexpression of these genes, together with the third biosynthetic serA
gene, serA197, encoding an L-serine-insensitive 3-phosphoglycerate dehydrogenase, yielded only traces of
L-serine, as did the overexpression of these genes in a strain with the L-serine dehydratase gene sdaA deleted.
However, reduced expression of the serine hydroxymethyltransferase gene glyA, in combination with the
overexpression of serA197, serC, and serB, resulted in a transient accumulation of up to 16 mM L-serine in the
culture medium. When sdaA was also deleted, the resulting strain, C. glutamicum sdaA::pK18mobglyA
(pEC-T18mob2serA197CB), accumulated up to 86 mM L-serine with a maximal specific productivity of 1.2 mmol
h1 g (dry weight)1. This illustrates a high rate of L-serine formation and also utilization in the C. glutamicum
wild type. Therefore, metabolic engineering of L-serine production from glucose can be achieved only by
addressing the apparent key position of this amino acid in the central metabolism.
The demand of L-serine is about 300 tons per year, and
this amino acid is required for the pharmaceutical and the
cosmetic industries, in addition to being a building block for
chemical and biochemical purposes (6). The current pro-
duction relies mainly on its enzymatic or cellular conversion
from the precursor glycine plus a C1 compound. Utilizing
the condensing activity of serine hydroxymethyltransferase,
an enzymatic system has been elaborated to convert glycine
plus formaldehyde to L-serine (15). The cellular systems
employed, among others, resting cells of methanol-utilizing
bacteria such as Hyphomicrobium methylovorum where
L-serine accumulation from glycine plus methanol was
achieved (16). Also, a fermentative production of L-serine
from glycine alone by Corynebacterium glycinophilum was
described (19). However, there is not much information on
the direct fermentative production of L-serine from glucose.
Attempts to isolate L-serine-producing strains using differ-
ent bacteria by applying undirected mutagenesis yielded mu-
tants accumulating only traces of L-serine (38). Apparently,
the direct conversion of glucose is a demanding challenge,
probably due to the role of L-serine as a central intermediate
for a number of cellular reactions (Fig. 1).
We are interested in the amino acid-synthesizing capabilities
of Corynebacterium glutamicum, which is traditionally used for
the large-scale production of L-glutamate and L-lysine (9). In
general, the efforts to engineer producing strains were focused
on the enzymes of the biosynthesis pathways. For instance,
considerable formation of L-lysine resulted in the deregulation
of the key enzyme aspartate kinase (4). Using similar ap-
proaches, C. glutamicum strains were developed by overpro-
ducing L-isoleucine, L-valine, L-threonine, or D-pantothenate
(8, 13). Besides the supply of precursors (29, 31) or reducing
power (23), export of amino acids was also found to be relevant
(7). Another focus of strain development was degradation. For
instance, production of L-threonine with C. glutamicum could
be increased by decreasing its intracellular degradation (33)
and in fact, one of the reasons for the success of L-lysine
formation with C. glutamicum was its inability to degrade the
product L-lysine. Thus, for the production of specific amino
acids, a number of cellular reactions have to be considered in
the ensemble and not just the biosynthesis pathway alone.
Since there is not yet a convincing strain for L-serine pro-
duction from glucose, we met the challenge to engineer
C. glutamicum for this purpose. In C. glutamicum as in other
bacteria, L-serine is synthesized via phosphorylated intermediates
starting with the glycolytic intermediate 3-phosphoglycerate,
which is oxidized to phosphohydroxypyruvate. Subsequent
transamination leads to the formation of phosphoserine, which
is dephosphorylated to yield L-serine (Fig. 1). We have previ-
ously studied 3-phosphoglycerate dehydrogenase (PGDH;
serA) from C. glutamicum catalyzing the initial reaction of the
three-step pathway of L-serine biosynthesis (30). As a result of
deleting the 197 carboxy-terminal amino acids of the SerA
polypeptide, PGDH activity is no longer inhibited by L-serine
(30). C. glutamicum possesses a high capacity to degrade
L-serine in the presence of glucose, and we could demonstrate
that sdaA-encoded L-serine dehydratase is involved in L-serine
degradation (24). Based on these studies, we describe here the
construction of an L-serine-producing strain from C. glutami-
cum by metabolic engineering.
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MATERIALS AND METHODS
Bacteria and plasmids. Bacterial strains and plasmids used in this work are
listed in Table 1.
Growth conditions. Luria-Bertani medium (LB) was used as the standard
medium for Escherichia coli, while brain heart infusion medium (BHI; Difco) was
used as complex medium for C. glutamicum. As minimal medium, CGXII was
used (17), but including 30 mg protocatechuic acid l1 and 220 mM glucose as a
carbon source. When appropriate, E. coli strains were cultured with carbenicillin
(50 g ml1), kanamycin (50 g ml1), chloramphenicol (20 g ml1), or
tetracycline (5 g ml1) and C. glutamicum strains with kanamycin (25 g ml1)
or tetracycline (5 g ml1). A reduced concentration of kanamycin (15 g ml1)
or tetracycline (4 g ml1), respectively, was used to obtain transformants of
C. glutamicum. E. coli was grown at 37°C and C. glutamicum at 30°C in 50 ml
medium in 500 ml baffled shake flasks and 120 rpm agitation. Strains harboring
the chromosomally integrated plasmid pK18mobglyA were cultivated in the
presence of 100 M isopropyl--thiogalactoside (IPTG). For L-serine production
experiments, these strains were cultivated without IPTG.
Isolation of serine-auxotrophic mutants and localization of transposon inser-
tion sites. The transposon (Tn) delivery vector pCGL0040 was isolated from
E. coli GM2929 grown in the presence of 50 g of kanamycin and 20 g of
chloramphenicol ml1 (1). The plasmid was used to transform C. glutamicum
ATCC 14752 to kanamycin resistance by using LBHIS plates (20) with 15 g of
kanamycin ml1. The resulting Tn mutants were transferred to CGXII plates
containing 25 g of kanamycin ml1 and either no peptide or a 3 mM concen-
tration of the dipeptide Ser-Ala. Four clones that exhibited only growth in the
presence of Ser-Ala were isolated. These clones were retrieved from the LBHIS
master plate and tested on CGXII plates containing 25 g of kanamycin ml1, 2
mM Ser-Ala, 1 mM L-serine, 1 mM L-alanine, or no supplement. Three mutants
required Ser-Ala or L-serine for growth. The cloning and sequencing of the Tn
insertion site in these mutants was performed as described previously (32).
Construction of plasmids and strains. Plasmids were constructed in E. coli
DH5MCR from PCR-generated fragments (Expand High Fidelity PCR kit;
Roche Diagnostics) by using C. glutamicum ATCC 13032 DNA as a template
prepared according to a method described elsewhere (10). E. coli was trans-
formed by the RbCl2 method (12) and C. glutamicum via electroporation (36).
All transformants were analyzed by plasmid analysis and/or PCR with appropri-
ate primers, respectively.
In order to construct pEC-T18mob2serCB, serC and serB were amplified by
FIG. 1. Scheme of L-serine biosynthesis and its metabolism in
C. glutamicum during growth on glucose. Dotted arrows represent
pathways consisting of more than one reaction. Genes are given in
italics.
TABLE 1. Strains and plasmids used
Strain or plasmid Relevant characteristicsa Source or reference
E. coli strains
DH5MCR endA1 supE44 recA1 gyrA96 relA1 deoR U169 80dlacZM15 mcrA
(mrr-hsdRMS-mcrBC)
11
GM2929 dam-13::Tn9 dcm-6 hsdR2 recF143 mcrA mcrB 27
C. glutamicum strains
WT Wild type, ATCC 13032 ATCCb
ATCC 14752 Requires biotin ATCC
WTsdaA WT carrying a deletion in the sdaA gene 24
WT::pK18mobglyA WT with glyA under control of tac promoter 32
WTsdaA::pK18mobglyA WTsdaA with glyA under control of tac promoter This work
Plasmids
pCGL0040 Donor of Tn5531 (IS1207, Kmr), AproriVEc U53587
c
pUC18 Cloning vector; Apr 26
pUC18serC pUC18 with 1.8-kb PCR product containing serC This work
pUC18serB pUC18 with 1.8-kb PCR product containing serB This work
pUC18serCB Ligation of 3.5-kb NotI-ScaI fragment from pUC18serC with 2.8-kb NotI-ScaI
fragment from pUC18serB
This work
pUC18serA197 pUC18 with 1.25-kb PCR fragment containing serA with a deletion of 197 aa at
the C terminus
30
pZ1serA pZ1 with 1.9-kb EcoRI-BamHI fragment from pUC18serA containing serA 30
pZ1serA197 pZ1 with 1.3-kb EcoRI-BamHI fragment from pUC18serA197 containing serA197 30
pEC-T18mob2 E. coli-C. glutamicum shuttle vector, Tetr 35
pEC-T18mob2serCB pEC-T18mob2 with 3.6-kb EcoRI-XbaI fragment containing serC and serB from
pUC18serCB
This work
pEC-T18mob2serA197CB pEC-T18mob2serCB with 3.6-kb EcoRI-XbaI fragment containing serC and serB
from pUC18serCB
This work
pK18mobglyA Mobilizable vector, nonreplicative in C. glutamicum, Kmr, containing lacIq
and Ptac fused to 5-terminal fragment of glyA
32
a Kmr, kanamycin resistance; Apr, ampicillin resistance; Cmr, chloramphenicol resistance.
b ATCC, American Type Culture Collection.
c GenBank accession number.
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PCR using the upstream primers serC-upper (5-GACCACCCACAGCCACCG
TAATC-3; the nucleotide (nt) corresponding to nt 877628 of NC003450 is
underlined) and serB-upper (5-GCGGCCGCGTTGATGATCCTTGGGGTTA
CG-3; the nucleotide corresponding to nt 2671294 of NC003450 is underlined),
respectively, and the respective reverse primers serC-lower (5-GCGGCCGCTT
TCCCGCATGTTGACTCCTTCTA-3; the nucleotide corresponding to nt
875874 of NC003450 is underlined) and serB-lower (5-GAAGGATCCTCGCT
ATGTGG-3; the nucleotide corresponding to nt 2669483 of NC003450 is un-
derlined). Boldfaced nucleotides correspond to the introduction of a NotI re-
striction site. The PCR fragments were blunted and cloned into the SmaI site of
pUC18. The obtained plasmids, pUC18serC and pUC18serB, were digested with
ScaI and NotI, and the inserts containing serC and serB were isolated and ligated
together, resulting in plasmid pUC18serCB. The plasmid was digested with
EcoRI and XbaI, and the serCB-containing insert obtained was ligated into
EcoRI- and XbaI-treated pEC-T18mob2, resulting in plasmid pEC-
T18mob2serCB.
To construct pEC-T18mob2serA197CB, plasmid pUC18serA197 (30) was
digested with EcoRI and BamHI and the serA197-containing insert obtained
was blunted and ligated in EcoRI-linearized and blunted plasmid pEC-
T18serCB.
In order to place the glyA gene in the chromosome of C. glutamicum under the
control of the IPTG-inducible tac promoter, the respective strains were trans-
formed via electroporation with the nonreplicative plasmid pK18mobglyA to
kanamycin resistance. Selection for kanamycin resistance was performed in the
presence of 100 M IPTG. The correct integration into the chromosome via
homologous glyA sequences was verified by PCR with appropriate primer pairs
and controls. The resulting mutants carried one intact copy of glyA under the
control of the inducible tac promoter and one incomplete copy under its own
promoter.
Enzyme assays. Phosphoserine phosphatase activity was analyzed as previously
described (3) by the determination of inorganic phosphate (Pi) released from
phosphoserine. Assays were performed discontinuously in mixtures (100 l)
containing 20 mM Tris-HCl (pH 7.5), 1 mM MgCl2, and 5 mM phosphoserine.
The reaction was stopped after 5 and 10 min by adding 10 l of 0.2 M EDTA and
placing it on ice. The amount of Pi released was determined with an EnzChek
phosphate assay kit (Molecular Probes) as described previously.
Serine hydroxymethyltransferase was assayed discontinuously by the quantifi-
cation of glycine formed from serine and 5,10-methylene tetrahydrofolate via
high-performance liquid chromatrography as previously described (33).
3-Phosphoglycerate dehydrogenase activity was determined spectrophoto-
metrically by the formation of NADH as described elsewhere (30).
RESULTS
Identification of the genes coding for phosphoserine amino-
transferase and phosphoserine phosphatase. While the serA
gene was known (30), the aim was to identify the complete
L-serine biosynthetic pathway in C. glutamicum. Therefore, we
used a recently established transposon mutant bank of C. glu-
tamicum ATCC 14752 with Tn5531 to screen for L-serine auxo-
trophs (18). Three clones unable to grow on minimal medium
CGXII unless supplemented with 1 mM L-serine were identi-
fied. Sequencing of the transposon flanking regions revealed
that in two mutants, the insertions were at different sites within
the open reading frame NCgl2436, whereas in the remaining
mutant, the insertion was apparently in the promoter region of
NCgl0794, 35 nucleotides upstream of the deduced open read-
ing frame. The latter open reading frame encodes a polypep-
tide of 376 amino acids which exhibits identities of 20% over its
entire length to the phosphoserine aminotransferase (PSAT;
serC) of E. coli (14). NCgl2436 encodes a deduced polypeptide
of 433 amino acids and its C-terminal half shares 41% identical
amino acids with the phosphoserine phosphatase (PSP, serB)
from E. coli (25). Interestingly, the N-terminal half of the
C. glutamicum polypeptide, which exhibits an ACT-like do-
main (2), is absent from the E. coli PSP, which is 93 amino
acids shorter. The sequence similarities to E. coli and the
serine auxotrophy of the transposon mutants identified the
genes as serC and serB from C. glutamicum. Additionally, we
constructed plasmid pEC-T18mob2serCB carrying both genes.
With this moderate-copy-number plasmid, the PSP activity was
increased threefold, from 110 nmol min1 mg (protein)1 in
the wild type (WT) to 320 nmol min1 mg (protein)1 in strain
WT(pEC-T18mob2serCB). Furthermore, we demonstrated
that this plasmid complemented the serC and serB transposon
mutants as expected (not shown).
Influence of the overexpression of the L-serine biosynthesis
genes on L-serine accumulation. We previously showed that
truncation of serA from C. glutamicum by 197 amino acids at its
C terminus (encoded by the serA197 allele) provided a 3-phos-
phoglycerate dehydrogenase devoid of feedback inhibition by
L-serine (30). Here, we studied whether overexpression of serA
or serA197 is sufficient to increase L-serine accumulation in the
WT. Therefore, the strains WT(pZ1serA)(pEC-T18mob2) and
WT(pZ1serA197)(pEC-T18mob2) were grown in minimal me-
dium with 220 mM glucose as the carbon source and the
L-serine concentration in the culture medium was determined
(Table 2). However, neither the overexpression of mutant
serA197 nor the WT allele yielded significant L-serine concen-
trations. Enzyme assays confirmed, for WT(pZ1serA) (pEC-
T18mob2), a specific PGDH activity of 700 nmol (min mg)1
and for WT(pZ1serA197) (pEC-T18mob2), a specific activity
of 690 nmol (min mg)1 equivalent to an 8- to 10-fold over-
expression compared to the WT (30).
In order to test whether the additional expression of serC and
serB or even their expression alone resulted in L-serine accumu-
lation, the respective strains WT(pZ1)(pEC-T18mob2serCB),
WT(pZ1serA)(pEC-T18mob2serCB), and WT(pZ1serA197)
(pEC-T18mob2serCB) were constructed. Surprisingly, also
with these strains, no substantial L-serine accumulation oc-
curred (Table 2).
Influence of deletion of sdaA on L-serine accumulation.
Based on the result that the overexpression of the serine bio-
synthetic genes is not sufficient for L-serine production and our
previous observation of a significant contribution of sdaA-en-
coded L-serine dehydratase (L-SerDH) to L-serine degradation
in C. glutamicum (24), we used the wild-type derivative con-
taining the sdaA deletion (WTsdaA) to assay for the influence
of the overexpression of the L-serine biosynthetic genes serA,
TABLE 2. L-Serine accumulation of various C. glutamicum strains
Strain
L-Serine concn (mM)a at:
28 h 54 h
WT 	0.01 	0.01
WT(pZ1)(pEC-T18mob2) 	0.01 	0.01
WT(pZ1serA)(pEC-T18mob2) 	0.01 0.12 
 0.10
WT(pZ1serA197)(pEC-T18mob2) 	0.01 0.08 
 0.05
WT(pZ1)(pEC-T18mob2serCB) 	0.01 0.04 
 0.03
WT(pZ1serA)(pEC-T18mob2serCB) 	0.01 0.11 
 0.03
WT(pZ1serA197)(pEC-T18mob2serCB) 	0.01 0.05 
 0.02
WT sdaA(pZ1)(pEC-T18mob2) 0.08 
 0.03 0.05 
 0.01
WT sdaA(pZ1serA)
(pEC-T18mob2serCB)
0.09 
 0.01 0.15 
 0.01
WT sdaA(pZ1serA197)
(pEC-T18mob2serCB)
0.44 
 0.28 0.14 
 0.01
a L-Serine accumulation was determined on minimal medium CGXII with
220 mM glucose in two or three independent experiments.
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serA197, serC, and serB on L-serine accumulation in this back-
ground (Table 2). The control strain WTsdaA(pZ1)(pEC-
T18mob2) accumulated 0.08 mM L-serine after 28 h of culti-
vation and 	0.05 mM after 54 h, showing that at the early time
point, sdaA deletion alone resulted in traces of L-serine.
C. glutamicum WTsdaA(pZ1serA)(pEC-T18mob2serCB) ac-
cumulated 0.09 mM L-serine after 24 h and up to 0.15 mM
after 54 h, showing a slight increase in L-serine accumulation
compared to the control. However, with strain WTsdaA
(pZ1serA197)(pEC-T18mob2serCB), 0.44 mM (28 h) and 0.14
mM (54 h) L-serine concentrations were determined. This
comparison shows an advantage of the serA197 allele over serA
but that, despite the deletion of sdaA, degradation of L-serine
is still occurring.
Influence of reduced serine hydroxymethyltransferase activ-
ity on L-serine accumulation. In growing C. glutamicum, only
16% of the L-serine synthesized is incorporated into protein
(21) whereas the remainder is cleaved by serine hydroxymeth-
yltransferase (SHMT; glyA) to provide 5,10-methylene tetra-
hydrofolate and glycine. A reduced activity of SHMT was al-
ready shown to be favorable for L-threonine production with
C. glutamicum due to an L-threonine-degrading side activity of
the enzyme. Since the glyA gene could not be deleted or dis-
rupted in C. glutamicum, even when supplemented with glycine
(33), plasmid pK18mobglyA was employed to reduce the SHMT
activity by replacing the native glyA promoter with the IPTG-
inducible tac promoter (33). We used strain WT::pK18mobglyA
to analyze the influence of a reduced SHMT activity on
L-serine production. In the first experiments, this strain already
accumulated up to 1 mM L-serine (not shown), illustrating the
principal importance of SHMT reduction for L-serine accumu-
lation. In order to overexpress serA197 together with serC and
serB in the kanamycin-resistant strain WT::pK18mobglyA, all
three genes were cloned into vector pEC-T18mob2 (35) to
generate pEC-T18serA197CB (see Materials and Methods).
Using this tetracycline resistance-conferring plasmid, strain
WT::pK18mobglyA(pEC-T18serA197CB) was generated.
This strain was cultivated with or without 100 M IPTG in
minimal medium CGXII containing 220 mM glucose as the
carbon source. Whereas in the presence of IPTG, the SHMT
activity was 40 nmol min1 mg (protein)1, it was 10 nmol
min1 mg (protein)1 without IPTG, confirming the successful
application of pK18mobglyA. With IPTG, L-serine accumula-
tion was below 1 mM (not shown), but in the absence of the
inducer, up to 16 mM L-serine accumulated (Fig. 2). Rate
calculations showed that constant specific productivities of
about 0.4 mmol h1 g (dry weight)1 occurred within 8 to 20 h
of the cultivation. However, almost all L-serine was degraded
again, which is consistent with our prior finding of the strong
utilization of externally added L-serine by C. glutamicum unless
L-SerDH (sdaA) was deleted (24).
Influence of combining the deletion of sdaA with reduced
SHMT activity on growth and L-serine accumulation. We used
plasmid pK18mobglyA to exchange the native glyA promoter
with the tac promoter in strain WTsdaA as well as plasmid
pEC-T18mob2serA197CB to overexpress the L-serine biosyn-
thesis genes. The resulting strain, WTsdaA::pK18mobglyA
(pEC-T18mob2serA197CB), was cultivated on CGXII me-
dium with 220 mM glucose as the carbon source. In order to
reduce glyA expression, IPTG was omitted. Enzyme activity
determinations confirmed the expected low SHMT activity
(not shown). A typical cultivation profile is shown in Fig. 3.
L-Serine accumulated up to about 86 mM in the culture me-
dium, with a maximum specific productivity of 1.2 mmol h1 g
(dry weight)1 at about 20 h and a molar yield (YP/S) of 0.64
mol/mol. This confirmed the positive effect of sdaA deletion,
which was also visible, although at a drastically reduced level
when just the L-serine biosynthesis genes were overexpressed,
without reducing SHMT activity (see above). Despite the ef-
ficient L-serine production with strain WTsdaA::pK18mob
glyA(pEC-T18mob2serA197CB), there was still significant
degradation of L-serine at later time points (Fig. 3). A com-
parison of the growth rates of the different genetically modified
strains with that of the wild type revealed that overexpression
of the genes serA197, serC, and serB alone or in combination
with a deletion of the sdaA gene resulted in a decreased growth
rate (Table 3). The largest reduction of growth rate was ob-
FIG. 2. Growth (■), glucose () and L-serine (F) concentrations in
the medium, and specific L-serine productivity (‚) of strain WT::
pK18mobglyA(pEC-T18mob2serA197CB) on minimal medium with
220 mM glucose. OD600, optical density at 600 nm; dw, dry weight.
FIG. 3. Growth (■), glucose () and L-serine (F) concentrations
in the medium, and specific L-serine productivity (‚) of strain
WTsdaA::pK18mobglyA(pEC-T18mob2serA197CB) on minimal
medium with 220 mM glucose. OD600, optical density at 600 nm; dw,
dry weight.
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served as a consequence of reduced glyA expression. The
strains WT::pK18mobglyA(pEC-T18mob2serA197CB) and
WTsdaA::pK18mobglyA(pEC-T18mob2serA197CB) exhib-
ited three- to fourfold-decreased growth rates under produc-
tion conditions compared to the wild type and a twofold rate
compared to the respective strains without reduced glyA ex-
pression (Table 3). This corroborates our previous finding that
a reduced SHMT activity correlates with a reduced growth rate
(33).
DISCUSSION
Our functional studies identified the PSAT (serC) and PSP
(serB) of Corynebacterium glutamicum. Although there are two
further open reading frames (NCgl0400, NCgl0294) annotated
as PSP in the genome of C. glutamicum, only NCgl2436 en-
codes a functional PSP. PSP of C. glutamicum contains 433
amino acyl residues, and its N terminus is extended by 93, 198,
and 190 residues compared to the PSP proteins from E. coli,
Methanococcus jannaschii, and humans, respectively (25, 28,
37). Notably, the additional N-terminal segment of C. glutami-
cum PSP includes a domain with similarity to an “ACT do-
main” that has been found in a number of proteins, including
PGDH of E. coli, Mycobacterium tuberculosis, and C. glutami-
cum (2, 5, 30). This domain is proposed to represent a con-
served regulatory ligand binding fold, but experimental evi-
dence for PSP is absent. The N-terminal extension as
characteristic for the C. glutamicum PSP is also present in that
of M. tuberculosis (Rv3042c) and in PSPs of other Actinomyc-
etales. On the other hand, PSAT of C. glutamicum has high
identity (61%) to the protein of M. tuberculosis (Rv0884c) but
only reduced identity (20%) to that of E. coli (14). The struc-
tural differences between PSAT from C. glutamicum and
E. coli might be due to a second enzymatic function which is
present only in the E. coli protein and which is involved in
pyridoxal-5-phosphate synthesis. These differences are also
apparent from the fact that only the N-terminal part of the
C. glutamicum PSAT protein, but the entire E. coli PSAT pro-
tein, is classified as an aminotransferase class V (pfam00266).
The wild-type serA derivative and the serA197 allele were
overexpressed either alone or in combination with the genes
serB and serC, but L-serine accumulated only in traces not
exceeding 0.1 mM. This distinguishes L-serine accumulation
from, for instance, L-lysine formation by C. glutamicum, where
deregulation of the initial enzyme of the pathway already re-
sults in substantial L-lysine accumulation of around 40 mM (4),
indicating that intracellular L-serine turnover precludes its pro-
duction. This is corroborated by our findings that L-serine
production was high only when glyA expression was reduced
and L-serine dehydratase activity absent. The corresponding
strain WTsdaA::pK18mobglyA(pEC-T18mob2serA197CB)
accumulated L-serine up to 86 mM, which is in the same range
as that observed for L-threonine accumulation with a respec-
tive threonine-producing C. glutamicum strain (33). Moreover,
this strain produced a yield of 0.64 mol L-serine per mol glu-
cose, which is about two- to sixfold higher than that obtained
with processes where glycine or glycine plus methanol were
used as substrates (16, 19). However, the reduced glyA expres-
sion in the L-serine-producing strain led to a slower growth rate
and a lower final optical density compared to a strain with
native glyA expression likely due to perturbation of the C-1
metabolism. Moreover, since the deletion of sdaA alone or in
combination with overexpression of the L-serine biosynthetic
genes did not result in an appreciable L-serine accumulation, it
is inconclusive whether a significant intracellular flux increase
due to the overexpression of the serA alleles together with serB
and serC is present. These results denote that the L-serine
pathway is a rather unusual amino acid biosynthesis pathway.
This idea is supported by the atypical PGDH (serA) inhibition
of C. glutamicum (30) and the facts that the equilibrium of the
PGDH-catalyzed reaction is on the substrate side (34) and an
ACT domain is present in PSP (serB).
Nevertheless, reduction of the glyA-encoded SHMT activity
had clearly the major impact on L-serine accumulation. Al-
ready, the reduction of glyA expression alone resulted in an
approximate 1 mM accumulation of L-serine (not shown),
which was not the case upon sdaA deletion. The importance of
reduced SHMT activity is also evident when comparing the
maximal fluxes rates (Table 3). With SHMT reduction and
overexpression of the biosynthesis pathway genes, the growth
rate was 0.11 h1. The calculated flux over the pathway to
satisfy the need for cellular synthesis, like phospholipid syn-
thesis and C1 generation under these conditions, is 2.75 nmol
min1 mg (dry weight)1 (22). Taking a maximal L-serine
excretion rate of 10 nmol min1 mg (dry weight)1 into ac-
count (Fig. 2), a total L-serine flux of 12.75 nmol min1 mg (dry
weight)1 resulted (Table 3). Importantly, the comparison of
this strain with the WT and WTDsdaA (pEC-T18mob2
serA197CB) illustrates that reducing the L-serine degradation
to glycine and C1 units favors an increased total L-serine flux,
indicative of a stimulation of the L-serine synthesis probably
due to a reduced availability of glycine and C1 units (Table 3).
The strong increase in L-serine flux by 11.02 to 23.75 nmol
min1 mg (dry weight)1 due to the additional sdaA deletion
TABLE 3. Comparison of L-serine fluxesa in recombinant C. glutamicum strains
Characteristics WT WT(pserA)(pserCB)b
WTsdaA
(pserA)(pserCB)b
WT::pK18mobglyA
(pserACB)c
WTsdaA::pK18mobglyA
(pserACB)c
max
d (h1) 0.38 0.26 0.21 0.11 0.11
Serine flux for cellular demand 9.50 6.5 5.25 2.75 2.75
Serine excretion flux 0 0 0 10 21
Sum of serine fluxes 9.5 6.5 5.25 12.75 23.75
a Fluxes are the maximal fluxes observed in nmol min1 mg (dry weight)1.
b (pserA)(pserCB) stands for (pZ1serA197)(pEC-T18mob2serCB).
c pserACB stands for (pEC-T18mob2serA197CB).
d max, maximum growth rate.
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in WTDsdaA::pK18mobglyA (pEC-T18mob2serA197CB) is
largely in agreement with the difference in the L-serine degra-
dation rates observed for the wild type and its sdaA deletion
mutant with externally added L-serine where the sdaA deletion
caused a decrease in L-serine degradation by 7.7 nmol min1
mg (dry weight)1 (24). This work demonstrates that engineer-
ing L-serine production from glucose requires considering the
position of L-serine in metabolism instead of considering L-
serine as an end product of a biosynthetic pathway.
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